Cutaneous adverse events in tremelimumab, a second-generation anti-CTLA4 inhibitor

Welborn, M; Kubicki, S; Patel, A

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017; 76 (6): AB88